The described devices relate generally to microwave antenna probes and methods of their use, e.g., in tissue ablation applications. More particularly, the described devices relate to microwave antennas that may be inserted directly into tissue for diagnosis and treatment of diseases.
In the treatment of diseases such as cancer, certain types of cancer cells have been found to denature at elevated temperatures (which are slightly lower than temperatures normally injurious to healthy cells). These types of treatments, known generally as hyperthermia therapy, typically utilize electromagnetic radiation to heat diseased cells to temperatures above 41° C. while maintaining adjacent healthy cells at lower temperatures where irreversible cell destruction will not occur. Other procedures utilizing electromagnetic radiation to heat tissue also include ablation and coagulation of the tissue. Such microwave ablation procedures, e.g., such as those performed for menorrhagia, are typically done to ablate and coagulate the targeted tissue to denature or kill it. Many procedures and types of devices utilizing electromagnetic radiation therapy are known in the art. Such microwave therapy is typically used in the treatment of tissue and organs such as the prostate, heart, and liver.
One non-invasive procedure generally involves the treatment of tissue (e.g., a tumor) underlying the skin via the use of microwave energy. The microwave energy is able to non-invasively penetrate the skin to reach the underlying tissue. However, this non-invasive procedure may result in the unwanted heating of healthy tissue. Thus, the non-invasive use of microwave energy requires a great deal of control. This is partly why a more direct and precise method of applying microwave radiation has been sought.
Presently, there are several types of microwave probes in use, e.g., monopole, dipole, and helical. One type is a monopole antenna probe, which consists of a single, elongated microwave conductor exposed at the end of the probe. The probe is sometimes surrounded by a dielectric sleeve. The second type of microwave probe commonly used is a dipole antenna, which consists of a coaxial construction having an inner conductor and an outer conductor with a dielectric separating a portion of the inner conductor and a portion of the outer conductor. In the monopole and dipole antenna probe, microwave energy generally radiates perpendicularly from the axis of the conductor.
The typical microwave antenna has a long, thin inner conductor which extends along the axis of the probe and is surrounded by a dielectric material and is further surrounded by an outer conductor around the dielectric material such that the outer conductor also extends along the axis of the probe. In another variation of the probe, which provides for effective outward radiation of energy or heating, a portion or portions of the outer conductor can be selectively removed. This type of construction is typically referred to as a “leaky waveguide” or “leaky coaxial” antenna. Another variation on the microwave probe involves having the tip formed in a uniform spiral pattern, such as a helix, to provide the necessary configuration for effective radiation. This variation can be used to direct energy in a particular direction, e.g., perpendicular to the axis, in a forward direction (i.e., towards the distal end of the antenna), or a combination thereof.
Invasive procedures and devices have been developed in which a microwave antenna probe may be either inserted directly into a point of treatment via a normal body orifice or percutaneously inserted. Such invasive procedures and devices potentially provide better temperature control of the tissue being treated. Because of the small difference between the temperature required for denaturing malignant cells and the temperature injurious to healthy cells, a known heating pattern and predictable temperature control is important so that heating is confined to the tissue to be treated. For instance, hyperthermia treatment at the threshold temperature of about 41.5° C. generally has little effect on most malignant growth of cells. However, at slightly elevated temperatures above the approximate range of 43° C. to 45° C., thermal damage to most types of normal cells is routinely observed. Accordingly, great care must be taken not to exceed these temperatures in healthy tissue.
However, many types of malignancies are difficult to reach and treat using non-invasive techniques or by using invasive antenna probes designed to be inserted into a normal body orifice, i.e., an easily accessible body opening. These types of conventional probes may be more flexible and may also avoid the need to separately sterilize the probe; however, they are structurally weak and typically require the use of an introducer or catheter to gain access to within the body. Moreover, the addition of introducers and catheters necessarily increase the diameter of the incision or access opening into the body thereby making the use of such probes more invasive and further increasing the probability of any complications that may arise.
Structurally stronger invasive probes exist and are typically long, narrow, needle-like antenna probes which may be inserted directly into the body tissue to directly access a site of a tumor or other malignancy. Such rigid probes generally have small diameters that aid not only in ease of use but also reduce the resulting trauma to the patient. A convenience of rigid antenna probes capable of direct insertion into tissue is that the probes may also allow for alternate additional uses given different situations. However, such rigid, needle-like probes may experience difficulties in failing to provide uniform patterns of radiated energy; and may fail to provide uniform heating axially along and radially around an effective length of the probe. Accordingly, it may be difficult to otherwise control and direct the heating pattern when using such probes.
Accordingly, there remains a need for a microwave antenna probe that may help in overcoming the problems discussed above. There also exists a need for a microwave antenna probe that is structurally robust enough for direct insertion into tissue without the need for additional introducers or catheters while producing a controllable and predictable heating pattern.
The described methods and devices provide for microwave antenna probes and their method of use, e.g., in tissue ablation applications. In some variations, the microwave antenna assembly has proximal and distal radiating portions. An inner and an outer conductor extend through the proximal radiating portion, with the inner conductor disposed within the outer conductor. The inner conductor further extends at least partially into the distal radiating portion. A junction member separates the proximal and distal radiation sections with at least a portion of the junction member disposed between the proximal and distal radiating portions. A reinforcing member is disposed longitudinally at least partially within the junction member and provides additional stiffness to the junction member, thereby increasing the overall structural integrity of the assembly and allowing for easier direct insertion of the assembly into tissue. The microwave antenna assembly may also comprise a sensor selected from the group consisting of a temperature sensor, a pressure sensor, and a flow sensor. In some variations, the sensor is a temperature sensor. Methods for assembling the disclosed microwave antenna assemblies are also described.
In certain variations, the reinforcing member extends from the junction member into the distal radiating portion. In other variations, the inner conductor extends through the reinforcing member. The inner conductor can be affixed to the distal radiating portion or can otherwise be placed into electrical communication with the distal radiating portion. In yet other variations, the reinforcing member itself can be integrally formed with the inner conductor as a single piece. In further variations, the inner conductor and distal radiating portion itself are integrally formed as a single piece. The proximal radiating portion may also be a single piece, and in some variations, the proximal radiating portion has a variable wall thickness. The microwave antenna assembly may also be connected to a source of microwave energy.
In another variation the microwave antenna assembly is further provided with a thermocouple for localized temperature sensing, with the thermocouple junction being positioned e.g., along the distal radiating portion. In yet a further variation, the microwave assembly is further provided with a lumen extending through at least a portion of the proximal radiating portion, or proximal to the proximal radiating portion, and opening to the surface of the assembly, for e.g., to deliver therapeutic agents to tissue, to provide a thermocouple or other temperature sensor, to act as an aspiration port for delivery or removal of fluids, or for the delivery of transducers or sensors to measure or sense various characteristics of the surrounding tissue and/or antenna performance.
To improve the energy focus of the antenna assembly, an electrical choke may also be used in any of the variations described herein to contain returning currents to the distal end of the antenna assembly. The choke may be disposed on top of a dielectric material on the antenna proximal of the radiating section. The choke is preferably comprised of a conductive layer and may be further covered by a tubing or coating to force the conductive layer to conform to the underlying antenna.
Additionally, variations on the choke, the tubing or coating, any sealant layers, as well as other layers that may be disposed over the antenna assembly may be used. Certain layers, e.g., a heatshrink layer disposed over the antenna assembly, may have wires or strands integrated within the layer to further strengthen the antenna assembly. Kevlar wires, for instance, may be integrally formed into the layer and oriented longitudinally with the antenna axis to provide additional strength.
During invasive treatment of diseased areas of tissue in a patient, trauma may be caused to the patient resulting in pain and other complications. Various microwave antenna assemblies, as described herein, are less traumatic than devices currently available and as described in further detail below, methods of manufacturing such devices are also described. Generally, the devices and assemblies described here allow for the direct insertion of a microwave antenna into tissue for the purposes of diagnosis and treatment of disease.
In certain applications, a microwave antenna requires adequate structural strength to prevent bending of the antenna, e.g., where the antenna is directly inserted into tissue, where the antenna undergoes bending moments after insertion, etc.
Accordingly, there are various configurations designed to increase the antenna strength. Such configurations include those described in U.S. Pat. No. 6,878,147 filed Nov. 2, 2001, which is incorporated herein by reference in its entirety. One configuration involves placing the antenna assembly under a compressive load to stiffen the radiating portions. Another configuration involves mechanically fastening, e.g., in a screw-like manner, the radiating portions together to provide a joint that will withstand bending moments. A further configuration involves creating overlapping joints between the radiating portions of the antenna assembly to provide a high-strength antenna. Many of these configurations will generally include a junction member disposed between and separating the proximal and distal radiating portions. As further detailed herein, the devices and assemblies described here provide for reinforcement members of various configurations that are disposed within the junction members to further stiffen and strengthen the overall assembly, without compromising the functionality of the assembly or its ease of manufacture.
Antenna Assembly with Reinforced Junction Member
Generally, the antenna assembly 10 in
In operation, microwave energy having a wavelength, λ, is transmitted through antenna assembly 30 along both proximal and distal radiating portions 36 and 38. This energy is then radiated into the surrounding medium, e.g., tissue. The length of the antenna for efficient radiation may be dependent at least on the effective wavelength, λeff, which is dependent upon the dielectric properties of the medium being radiated into. Energy from the antenna assembly 30 radiates and the surrounding medium is subsequently heated. An antenna assembly 30 though which microwave energy is transmitted at a wavelength, λ, may have differing effective wavelengths, λeff, depending upon the surrounding medium, e.g., liver tissue, as opposed to, e.g., breast tissue. Also affecting the effective wavelength, λeff, are coatings that may be disposed over antenna assembly 30, as discussed further below.
As can be seen, channel 60 extends axially through junction member 50 and receives reinforcing member 70 which is generally cylindrical and configured to be received within and extend through the channel 60. The reinforcing member is generally formed of a stronger and stiffer material than the junction member and thus reinforces the junction member. In the variation depicted the reinforcing member is integrally formed with inner conductor 44 and includes central section 72 that resides within junction member 50 and a distal section 74 that extends from the junction member distally into the distal radiating portion. Wire 78 extends distally from section 74 and is in electrical contact with the inner perimeter 21 of the distal radiating section 20. In this configuration, the reinforcing member thus functions to extend the inner conductor through the junction member and into the distal radiating section. The combination of the inner conductor 44, reinforcing member 70 and terminal wire 78 into a single piece has manufacturing and assembly advantages. The terminal wire 78 can be bent such that upon insertion into the distal radiating portion, it comes into contact with the perimeter 21. The piece can further include stop 76, which retains reinforcing member 70 against junction member 50 and prevents it from moving proximally relative to the reinforcing member. In alternative configurations, the reinforcing member can be a separate piece that allows for passage of the inner conductor through to the distal section. In such alternative configurations, the reinforcing member need not be electrically conductive and in many configurations it may be desirable for the reinforcing member to be formed of a dielectric material. This material, for example, may be chosen so as to retain optimal antenna characteristics.
Antenna Assembly with Reinforced Junction Member and Thermocouple
Antenna Assembly with Reinforced Junction Member and Cooling Chamber
A dielectric 446 is positioned longitudinally between inner conductor 444 and outer conductor 448 to electrically separate them, In this variation, a cooling tube 456 is positioned longitudinally adjacent to outer conductor 448, and a cooling jacket 458 is positioned longitudinally adjacent to cooling tube 456, making up a cooling chamber. While not shown if
Materials and Methods
Junction members used in the antenna assemblies described herein are preferably made of a dielectric material such as a ceramic or other suitable dielectric. Illustrative examples of suitable dielectric materials include, but are not limited to Al2O3, Boron Nitride, stabilized Zirconia, air, and the like. Alternatively, junction members can made of a metal and sufficiently coated with a dielectric or polymer (e.g., high temperature polymers like polyimide or Ultem™ provided the dielectric coating is sufficiently thick to provide adequate insulation. To prevent energy from conducting directly into the tissue during use, a dielectric layer having a thickness between about 0.0001 to 0.025 inches may be coated directly over the antenna assembly. The dielectric coating may increase the radiated energy and is preferably made from a ceramic material, such as Al2O3, TiO2, or the like, and may also be optionally further coated with a lubricious material such as Teflon™, polytetrafluoroethylene (PTFE), or fluorinated ethylene propylene (FEP), etc. In addition to the dielectric coating, a sealant layer may also be coated either directly over the antenna assembly, or preferably over the dielectric layer to provide a lubricious surface for facilitating insertion into a patient as well as to prevent tissue from sticking to the antenna assembly. The sealant layer may be any variety of polymer, but is preferably a thermoplastic polymer and may have a thickness varying from a few angstroms to as thick as necessary for the application at hand. The sealant layer may be made from a variety of thermoplastic polymers, e.g., heat shrink polymers, such as polyethylene (PE), polyethylene terephthalate (PET), polytetrafluoroethylene (PTFE), fluorinated ethylene propylene (FEP), perfluoroalkoxy (PFA), chlorotrifluoroethylene (CTFE), ethylene chlortrifluoroethylene (ECTFE), and ethylene tetrafluoroethylene (ETFE). Varying these coating thicknesses over antenna assembly may vary the effective wavelengths, λeff, of the radiation being transmitted by the antenna. Thus, one may vary the coating thicknesses over the assembly to achieve a predetermined effective wavelength depending upon the desired results.
A preferable method of optimizing the amount of radiated energy from the assembly may include adjusting the length of proximal radiating portion to correspond to a length of nλ/4 (where n is any integer) of the radiation being transmitted through assembly, and likewise adjusting a cumulative (or overall) length of distal radiating portion and junction to also correspond to a length of nλ/4. Adjusting the lengths of proximal and distal radiating portions to correspond to the wavelength of the transmitted microwaves may be done to optimize the amount of radiated energy and accordingly, the amount of the medium or tissue that is subsequently heated. The actual lengths of proximal and distal radiating portions may, of course, vary and is not constrained to meet any particular nλ/4 length. When an antenna assembly is radiating energy, the ablation field is variable 3-dimensionally and may be roughly spherical or ellipsoidal, which centers on the junction member and extends to the ends of the proximal and distal radiating portions.
The location of the distal tip may be proportional to a distance of nλ/4 of the radiation being transmitted through the assembly. However, since the distal tip typically terminates at tapered end, the angled surface of taper may be taken into account. Thus, the total distance along the outer surfaces of the junction member and distal radiating portion (including any tapered end) may accord to the distance of nλ/4. The length of proximal radiating portion may also accord to the distance of nλ/4, as above. Although it is preferable to have the length of the radiating portion of the antenna accord with a distance of the wavelength, k, it is not necessary for operation of the device, as described above. That is, an antenna assembly having a radiating portion with a length in accordance with a first wavelength may generally still be used for transmitting radiation having a second wavelength, or third wavelength, or so on, although with a possible reduction in efficiency. Also, while the variations described above are related to dipole antenna assemblies, monopole antenna assemblies are also contemplated.
To improve the energy focus of an antenna assembly, an electrical choke may also be used to contain returning currents to the distal end of the antenna, as is described in U.S. patent application Ser. No. 10/052,848 filed Nov. 2, 2001, now U.S. Pat. No. 6,878,147, which is incorporated herein by reference in its entirety. Generally, the choke may be disposed on the antenna proximal of the radiating section. The choke is preferably placed over a dielectric material, which may be disposed over the antenna. The choke is preferably a conductive layer and may be further covered by a tubing or coating to force the conductive layer to conform to the underlying antenna, thereby forcing an electrical connection (or short) more distally and closer to the radiating section. The electrical connection between the choke and the underlying antenna may also be achieved by other connection methods such as soldering, welding, brazing, crimping, use of conductive adhesives, and the like.
Additional steps may optionally be taken to further increase the strength of an antenna assembly by altering any of the layers, such as sealant layer or any of the other heatshrink layers discussed above. Wires or strands may be formed within, or on, the layers to add strength and are preferably orientated longitudinally along the length of the antenna such that the bending strength of the antenna is increased. The layers may be formed over the outer conductor, as described above, and the wires may be made of any high-strength material, e.g., Kevlar, metals, etc. Metal wires may be used, provided they are insulated.
Antenna Deployment
As described above, the microwave antenna may be inserted directly into the tissue and into the lesion to be treated. However, during insertion, the antenna may encounter resistance from some areas of tissue, particularly in some tissue found, e.g., in the breast. When the microwave antenna encounters resistance, if force were applied, tissue damage may result or the target tissue may be inadvertently pushed away due to the differential density of the target tissue relative to the surrounding tissue. Therefore, RF energy may also be utilized with the microwave antenna for facilitating deployment within the tissue.
In use, the RF energy may be simply left on the entire time the antenna is advanced through the tissue, or it may be applied or turned on only as needed as the antenna encounters resistance from the tissue. With the RF energy activated, the antenna may be further advanced utilizing the RF energy to cut through the obstructive tissue. Once the antenna has been desirably positioned within a lesion or region of tissue, the RF energy, if on, may be switched off and the microwave energy may be switched on to effect treatment.
In certain variations, the assembly may use RF energy at the distal tip of the antenna as a cutting mechanism during antenna deployment. The microwave antenna is preferably covered with some insulative material along most of its length, but distal tip may be uninsulated such that the FW energy may be applied thereto through the inner conductor. To utilize the RF energy cutting mechanism at the distal tip, the inner conductor may be made from Nitinol, Tungsten, stainless steel, or some other conductive metal.
The antenna assembly may be electrically connected to an RF generator that provides the RF energy to the distal tip during placement and positioning of the antenna within the tissue or lesion. After the antenna has been desirably positioned within the lesion, the connector may be disconnected from the RF cable and attached to a microwave generator via a microwave cable to provide the microwave energy for effecting treatment to the tissue.
Alternatively, given the small amount of surface area of the distal tip of the assembly, a low power FW generator may be utilized and can be built into an integral unit along with the microwave generator. Alternatively, an optional RF generator may be physically separated from the microwave generator and may be electrically connected as a separate unit to the antenna.
Aside from the illustrations of possible antenna deployment methods and devices described above, other variations for deployment and insertion into tissue may be utilized. Potential other methods and devices for antenna deployment and insertion may be found in U.S. Pat. No. 7,197,363, filed Sep. 15, 2002, which is commonly owned and is incorporated herein by reference in its entirety.
Methods of Use
In using a microwave antenna, several different methods may be utilized, including the use of single or multiple antennas, as is further described U.S. patent application Ser. No. 10/052,848 filed Nov. 2, 2001, now U.S. Pat. No. 6,878,147, which is incorporated herein by reference in its entirety.
The applications of the antenna assemblies and methods of making the assemblies discussed above are not limited to microwave antennas used for hyperthermic, ablation, and coagulation treatments but may include any number of further microwave antenna applications. Modification of the above-described assemblies and methods for carrying out the invention, and variations of aspects of the invention that are obvious to those of skill in the art are intended to be within the scope of the claims.
This application is a continuation of U.S. patent application Ser. No. 14/924,904, filed Oct. 28, 2015, now U.S. Pat. No. 10,537,386, which is a continuation of U.S. patent application Ser. No. 14/640,174, filed Mar. 6, 2015, now U.S. Pat. No. 9,186,216, which is a continuation of U.S. patent application Ser. No. 14/153,644, filed Jan. 13, 2014, now U.S. Pat. No. 8,974,452, which is a continuation of U.S. patent application Ser. No. 13/479,588, filed May 24, 2012, now U.S. Pat. No. 8,663,213, which is a continuation of U.S. patent application Ser. No. 13/214,503, filed Aug. 22, 2011, now U.S. Pat. No. 8,192,423, which is a continuation of U.S. patent application Ser. No. 12/859,841, filed Aug. 20, 2010, now U.S. Pat. No. 8,012,148, which is a continuation of U.S. patent application Ser. No. 11/126,531, filed May 10, 2005, now U.S. Pat. No. 7,799,019.
Number | Name | Date | Kind |
---|---|---|---|
4140130 | Storm, III | Feb 1979 | A |
4204549 | Paglione | May 1980 | A |
4292960 | Paglione | Oct 1981 | A |
4311154 | Sterzer et al. | Jan 1982 | A |
4375220 | Matvias | Mar 1983 | A |
4409993 | Furihata | Oct 1983 | A |
4534347 | Taylor | Aug 1985 | A |
4557272 | Carr | Dec 1985 | A |
4583869 | Chive et al. | Apr 1986 | A |
4612940 | Kasevich et al. | Sep 1986 | A |
4621642 | Chen | Nov 1986 | A |
4658836 | Turner | Apr 1987 | A |
4700716 | Kasevich et al. | Oct 1987 | A |
4776086 | Kasevich et al. | Oct 1988 | A |
4800899 | Elliott | Jan 1989 | A |
4823812 | Eshel et al. | Apr 1989 | A |
4841988 | Fetter et al. | Jun 1989 | A |
4945912 | Langberg | Aug 1990 | A |
5097845 | Fetter et al. | Mar 1992 | A |
5122137 | Lennox | Jun 1992 | A |
5190054 | Fetter et al. | Mar 1993 | A |
5221269 | Miller et al. | Jun 1993 | A |
5234004 | Hascoet et al. | Aug 1993 | A |
5246438 | Langberg | Sep 1993 | A |
5249585 | Turner et al. | Oct 1993 | A |
5275597 | Higgins | Jan 1994 | A |
5281217 | Edwards et al. | Jan 1994 | A |
5301687 | Wong et al. | Apr 1994 | A |
5314466 | Stern et al. | May 1994 | A |
5342355 | Long | Aug 1994 | A |
5344441 | Gronauer | Sep 1994 | A |
5366490 | Edwards et al. | Nov 1994 | A |
5370644 | Langberg | Dec 1994 | A |
5370676 | Sozanski et al. | Dec 1994 | A |
5383922 | Zipes et al. | Jan 1995 | A |
5405346 | Grundy et al. | Apr 1995 | A |
5413588 | Rudie et al. | May 1995 | A |
5433740 | Yamaguchi | Jul 1995 | A |
5458597 | Edwards et al. | Oct 1995 | A |
5464445 | Rudie et al. | Nov 1995 | A |
5480417 | Hascoet et al. | Jan 1996 | A |
5500012 | Brucker et al. | Mar 1996 | A |
5507743 | Edwards et al. | Apr 1996 | A |
5509929 | Hascoet et al. | Apr 1996 | A |
5520684 | Imran | May 1996 | A |
5536267 | Edwards et al. | Jul 1996 | A |
5545137 | Rudie et al. | Aug 1996 | A |
5556377 | Rosen et al. | Sep 1996 | A |
5599294 | Edwards et al. | Feb 1997 | A |
5599295 | Rosen et al. | Feb 1997 | A |
5628770 | Thome et al. | May 1997 | A |
5683382 | Lenihan et al. | Nov 1997 | A |
5720718 | Rosen et al. | Feb 1998 | A |
5741249 | Moss et al. | Apr 1998 | A |
5755754 | Rudie et al. | May 1998 | A |
5776176 | Rudie | Jul 1998 | A |
5800486 | Thome et al. | Sep 1998 | A |
5810803 | Moss et al. | Sep 1998 | A |
5810804 | Gough et al. | Sep 1998 | A |
5829519 | Uthe | Nov 1998 | A |
5843144 | Rudie et al. | Dec 1998 | A |
5871523 | Fleischman et al. | Feb 1999 | A |
5897554 | Chia et al. | Apr 1999 | A |
5902251 | vanHooydonk | May 1999 | A |
5904691 | Barnett et al. | May 1999 | A |
5904709 | Arndt et al. | May 1999 | A |
5916240 | Rudie et al. | Jun 1999 | A |
5931807 | McClure et al. | Aug 1999 | A |
5931860 | Reid et al. | Aug 1999 | A |
5938692 | Rudie | Aug 1999 | A |
5951547 | Gough et al. | Sep 1999 | A |
5957969 | Warner et al. | Sep 1999 | A |
5964755 | Edwards | Oct 1999 | A |
5974343 | Brevard et al. | Oct 1999 | A |
5980563 | Tu et al. | Nov 1999 | A |
5997532 | McLaughlin et al. | Dec 1999 | A |
6016452 | Kasevich | Jan 2000 | A |
6016811 | Knopp et al. | Jan 2000 | A |
6026331 | Feldberg et al. | Feb 2000 | A |
6032078 | Rudie | Feb 2000 | A |
6047216 | Carl et al. | Apr 2000 | A |
6056744 | Edwards | May 2000 | A |
6059780 | Gough et al. | May 2000 | A |
6063078 | Wittkampf | May 2000 | A |
6073051 | Sharkey et al. | Jun 2000 | A |
6080150 | Gough | Jun 2000 | A |
6097985 | Kasevich et al. | Aug 2000 | A |
6106518 | Wittenberger et al. | Aug 2000 | A |
6122551 | Rudie et al. | Sep 2000 | A |
6134476 | Arndt et al. | Oct 2000 | A |
6146379 | Fleischman et al. | Nov 2000 | A |
6176856 | Jandak et al. | Jan 2001 | B1 |
6181970 | Kasevich | Jan 2001 | B1 |
6217528 | Koblish et al. | Apr 2001 | B1 |
6223086 | Carl et al. | Apr 2001 | B1 |
6226553 | Carl et al. | May 2001 | B1 |
6233490 | Kasevich | May 2001 | B1 |
6235048 | Dobak, III | May 2001 | B1 |
6245064 | Lesh et al. | Jun 2001 | B1 |
6251128 | Knopp et al. | Jun 2001 | B1 |
6275738 | Kasevich et al. | Aug 2001 | B1 |
6277113 | Berube | Aug 2001 | B1 |
6289249 | Arndt et al. | Sep 2001 | B1 |
6290715 | Sharkey | Sep 2001 | B1 |
6306132 | Moorman et al. | Oct 2001 | B1 |
6325796 | Berube et al. | Dec 2001 | B1 |
6330479 | Stauffer | Dec 2001 | B1 |
6346104 | Daly et al. | Feb 2002 | B2 |
6347251 | Deng | Feb 2002 | B1 |
6350262 | Ashley | Feb 2002 | B1 |
6355033 | Moorman et al. | Mar 2002 | B1 |
6383182 | Berube et al. | May 2002 | B1 |
6405733 | Fogarty et al. | Jun 2002 | B1 |
6471696 | Berube et al. | Oct 2002 | B1 |
6496736 | Carl et al. | Dec 2002 | B1 |
6496737 | Rudie et al. | Dec 2002 | B2 |
6506189 | Rittman, III et al. | Jan 2003 | B1 |
6512956 | Arndt et al. | Jan 2003 | B2 |
6514251 | Ni et al. | Feb 2003 | B1 |
6530922 | Cosman et al. | Mar 2003 | B2 |
6564806 | Fogarty et al. | May 2003 | B1 |
6569159 | Edwards et al. | May 2003 | B1 |
6577903 | Cronin et al. | Jun 2003 | B1 |
6589234 | Lalonde et al. | Jul 2003 | B2 |
6592579 | Arndt et al. | Jul 2003 | B2 |
6640139 | Ueberle | Oct 2003 | B1 |
6663624 | Edwards et al. | Dec 2003 | B2 |
6675050 | Arndt et al. | Jan 2004 | B2 |
6685700 | Behl et al. | Feb 2004 | B2 |
6699241 | Rappaport et al. | Mar 2004 | B2 |
6706040 | Mahon et al. | Mar 2004 | B2 |
6722371 | Fogarty et al. | Apr 2004 | B1 |
6752154 | Fogarty et al. | Jun 2004 | B2 |
6752767 | Turovskiy et al. | Jun 2004 | B2 |
6823218 | Berube | Nov 2004 | B2 |
6852091 | Edwards et al. | Feb 2005 | B2 |
6878147 | Prakash et al. | Apr 2005 | B2 |
7128739 | Prakash et al. | Oct 2006 | B2 |
7147632 | Prakash et al. | Dec 2006 | B2 |
7174217 | Rioux et al. | Feb 2007 | B2 |
7190989 | Swanson et al. | Mar 2007 | B1 |
7207985 | Duong et al. | Apr 2007 | B2 |
7217282 | Ginsburg et al. | May 2007 | B2 |
7229437 | Johnson et al. | Jun 2007 | B2 |
7231259 | Jenney et al. | Jun 2007 | B2 |
7234225 | Johnson et al. | Jun 2007 | B2 |
7234977 | Westlund et al. | Jun 2007 | B2 |
7235070 | Vanney | Jun 2007 | B2 |
7238166 | Callister | Jul 2007 | B2 |
7238184 | Megerman et al. | Jul 2007 | B2 |
7238194 | Monstadt et al. | Jul 2007 | B2 |
7241293 | Davison | Jul 2007 | B2 |
7244254 | Brace et al. | Jul 2007 | B2 |
7245955 | Rashidi | Jul 2007 | B2 |
7264619 | Venturelli | Sep 2007 | B2 |
7270656 | Gowda et al. | Sep 2007 | B2 |
7270658 | Woloszko et al. | Sep 2007 | B2 |
7270659 | Ricart et al. | Sep 2007 | B2 |
7270661 | Dahla et al. | Sep 2007 | B2 |
7270662 | Visram et al. | Sep 2007 | B2 |
7271363 | Lee et al. | Sep 2007 | B2 |
7273480 | Young et al. | Sep 2007 | B2 |
7276061 | Schaer et al. | Oct 2007 | B2 |
7282049 | Orszulak et al. | Oct 2007 | B2 |
7285116 | de la Rama et al. | Oct 2007 | B2 |
7293562 | Malecki et al. | Nov 2007 | B2 |
7300438 | Falwell et al. | Nov 2007 | B2 |
7301131 | Gauthier et al. | Nov 2007 | B2 |
7306592 | Morgan et al. | Dec 2007 | B2 |
7309325 | Mulier et al. | Dec 2007 | B2 |
7309336 | Ashley et al. | Dec 2007 | B2 |
7311702 | Tallarida et al. | Dec 2007 | B2 |
7311703 | Turovskiy et al. | Dec 2007 | B2 |
7311705 | Sra | Dec 2007 | B2 |
7317949 | Morrison et al. | Jan 2008 | B2 |
7318822 | Darmos et al. | Jan 2008 | B2 |
7318823 | Sharps et al. | Jan 2008 | B2 |
7318824 | Prakash | Jan 2008 | B2 |
7319904 | Cross, Jr. et al. | Jan 2008 | B2 |
7326204 | Paul et al. | Feb 2008 | B2 |
7326205 | Paul et al. | Feb 2008 | B2 |
7326206 | Paul et al. | Feb 2008 | B2 |
7331957 | Woloszko et al. | Feb 2008 | B2 |
7337009 | Schell | Feb 2008 | B2 |
7410485 | Fink | Aug 2008 | B1 |
7799019 | Turovskiy et al. | Sep 2010 | B2 |
3012148 | Turovskiy et al. | Sep 2011 | A1 |
8192423 | Turovskiy et al. | Jun 2012 | B2 |
8663213 | Turovskiy et al. | Mar 2014 | B2 |
8974452 | Turovskiy et al. | Mar 2015 | B2 |
9186216 | Turovskiy et al. | Nov 2015 | B2 |
10537386 | Turovskiy et al. | Jan 2020 | B2 |
20010001819 | Lee et al. | May 2001 | A1 |
20010008966 | Arndt et al. | Jul 2001 | A1 |
20010020178 | Arndt et al. | Sep 2001 | A1 |
20010020180 | Arndt et al. | Sep 2001 | A1 |
20010037812 | Dobak et al. | Nov 2001 | A1 |
20020022832 | Mikus et al. | Feb 2002 | A1 |
20020087151 | Mody et al. | Jul 2002 | A1 |
20020133148 | Daniel et al. | Sep 2002 | A1 |
20020147444 | Shah et al. | Oct 2002 | A1 |
20020198520 | Coen et al. | Dec 2002 | A1 |
20030004506 | Messing | Jan 2003 | A1 |
20030065317 | Rudie et al. | Apr 2003 | A1 |
20030069578 | Hall et al. | Apr 2003 | A1 |
20030078573 | Truckai et al. | Apr 2003 | A1 |
20030088242 | Prakash | May 2003 | A1 |
20030109862 | Prakash et al. | Jun 2003 | A1 |
20030195499 | Prakash et al. | Oct 2003 | A1 |
20040078038 | Desinger et al. | Apr 2004 | A1 |
20040167517 | Desinger et al. | Aug 2004 | A1 |
20040168692 | Fogarty et al. | Sep 2004 | A1 |
20040243200 | Turner et al. | Dec 2004 | A1 |
20040267156 | Turovskiy et al. | Dec 2004 | A1 |
20050015081 | Turovskiy | Jan 2005 | A1 |
20050065508 | Johnson et al. | Mar 2005 | A1 |
20050085881 | Prakash | Apr 2005 | A1 |
20050107783 | Tom et al. | May 2005 | A1 |
20050148836 | Kleen et al. | Jul 2005 | A1 |
20050159741 | Paul et al. | Jul 2005 | A1 |
20060026492 | Rhee et al. | Feb 2006 | A1 |
20060028206 | Zhang et al. | Feb 2006 | A1 |
20060264923 | Prakash et al. | Nov 2006 | A1 |
20060282069 | Prakash et al. | Dec 2006 | A1 |
20070027451 | Desinger et al. | Feb 2007 | A1 |
20070073282 | McGaffigan et al. | Mar 2007 | A1 |
20070123765 | Hetke et al. | May 2007 | A1 |
20070129715 | Eggers et al. | Jun 2007 | A1 |
20070135879 | McIntyre et al. | Jun 2007 | A1 |
20070142829 | Ahn et al. | Jun 2007 | A1 |
20070149964 | Kawabata et al. | Jun 2007 | A1 |
20070156048 | Panescu et al. | Jul 2007 | A1 |
20070156128 | Jimenez | Jul 2007 | A1 |
20070156132 | Drysen | Jul 2007 | A1 |
20070156133 | McDaniel et al. | Jul 2007 | A1 |
20070173680 | Rioux et al. | Jul 2007 | A1 |
20070173798 | Adams et al. | Jul 2007 | A1 |
20070173812 | Bonan et al. | Jul 2007 | A1 |
20070179375 | Fuimaono et al. | Aug 2007 | A1 |
20070179497 | Eggers et al. | Aug 2007 | A1 |
20070185478 | Cosentino | Aug 2007 | A1 |
20070191825 | Cronin et al. | Aug 2007 | A1 |
20070203551 | Cronin et al. | Aug 2007 | A1 |
20070208334 | Woloszko et al. | Sep 2007 | A1 |
20070208335 | Woloszko et al. | Sep 2007 | A1 |
20070208383 | Williams | Sep 2007 | A1 |
20070213700 | Davison et al. | Sep 2007 | A1 |
20070213703 | Naam et al. | Sep 2007 | A1 |
20070215163 | Harrington et al. | Sep 2007 | A1 |
20070219551 | Honour et al. | Sep 2007 | A1 |
20070225701 | O'Sullivan | Sep 2007 | A1 |
20070233057 | Konishi | Oct 2007 | A1 |
20070244529 | Choi et al. | Oct 2007 | A1 |
20070250053 | Fernald et al. | Oct 2007 | A1 |
20070250054 | Drake | Oct 2007 | A1 |
20070250055 | Johnson et al. | Oct 2007 | A1 |
20070250056 | Vanney | Oct 2007 | A1 |
20070255276 | Sliwa et al. | Nov 2007 | A1 |
20070260235 | Podhajsky | Nov 2007 | A1 |
20070260237 | Sutton et al. | Nov 2007 | A1 |
20070270679 | Nguyen et al. | Nov 2007 | A1 |
20070270791 | Wang et al. | Nov 2007 | A1 |
20070276361 | Stevens-Wright et al. | Nov 2007 | A1 |
20070276362 | Rioux et al. | Nov 2007 | A1 |
20070282323 | Woloszko et al. | Dec 2007 | A1 |
20070282324 | Vaska et al. | Dec 2007 | A1 |
20070282325 | Young et al. | Dec 2007 | A1 |
20070287995 | Mayse | Dec 2007 | A1 |
20070287998 | Sharareh et al. | Dec 2007 | A1 |
20070293853 | Fruckai et al. | Dec 2007 | A1 |
20070293854 | Pless et al. | Dec 2007 | A1 |
20070293855 | Sliwa et al. | Dec 2007 | A1 |
20070299488 | Carr | Dec 2007 | A1 |
20080004614 | Burdette et al. | Jan 2008 | A1 |
20080004618 | Johnson et al. | Jan 2008 | A1 |
Number | Date | Country |
---|---|---|
0521264 | Jan 1993 | EP |
0667126 | Aug 1995 | EP |
9320767 | Oct 1993 | WO |
9320768 | Oct 1993 | WO |
9501814 | Jan 1995 | WO |
9634571 | Nov 1996 | WO |
9748449 | Dec 1997 | WO |
9748450 | Dec 1997 | WO |
9748451 | Dec 1997 | WO |
9956642 | Nov 1999 | WO |
9956643 | Nov 1999 | WO |
9956812 | Nov 1999 | WO |
0049957 | Aug 2000 | WO |
0057811 | Oct 2000 | WO |
0160235 | Aug 2001 | WO |
02078777 | Oct 2002 | WO |
03034932 | May 2003 | WO |
03039385 | May 2003 | WO |
03047043 | Jun 2003 | WO |
03088806 | Oct 2003 | WO |
03088858 | Oct 2003 | WO |
2005011049 | Feb 2005 | WO |
Entry |
---|
European Communication dated Nov. 9, 2016, corresponding to European Application No. 06 009 435.6; 5 pages. |
European Communication dated Aug. 1, 2017, corresponding to European Application No. 06 009 435.6; 3 pages. |
U.S. Pat. No. 5,326,343, Jul. 1994, Rudie et al. (withdrawn). |
I Chou, C.K. (1995). “Radiofrequency Hyperthermia in Cancer Therapy,” Biologic Effects of Nonionizing Electromagnetic Fields Chapter 94, CRCPress, Inc. pp. 1424/1428. |
Urologix, Inc.—Medical Professionals: Targis3 Technology http://www.urologix.com/medical/technology.html (total pp. 3). |
International Search Report—EP 06 00 9435 dated Jul. 13, 2006. |
Urologix, Inc.—Medical Professionals: Targis Technology http://www.urologix.com/medical/technology.html; 3 pages. |
International Search Report corresponding to European Application No. EP 06 00 9435.6, completed Jul. 6, 2006; dated Jul. 13, 2006; 3 pages. |
Official Action issued in the corresponding Japanese Application No. 2006-128689 dated Sep. 29, 2011. |
Number | Date | Country | |
---|---|---|---|
20200113629 A1 | Apr 2020 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14924904 | Oct 2015 | US |
Child | 16713312 | US | |
Parent | 14640174 | Mar 2015 | US |
Child | 14924904 | US | |
Parent | 14153644 | Jan 2014 | US |
Child | 14640174 | US | |
Parent | 13479588 | May 2012 | US |
Child | 14153644 | US | |
Parent | 13214503 | Aug 2011 | US |
Child | 13479588 | US | |
Parent | 12859841 | Aug 2010 | US |
Child | 13214503 | US | |
Parent | 11126531 | May 2005 | US |
Child | 12859841 | US |